# FDA Inspection 1304600 - Pfizer Inc. - February 13, 2026

Source: https://www.keypedia.com/records/fda_inspections/pfizer-inc/3bd4f335-3aa7-4631-8e45-18a5ede83441
Source feed: FDA_Inspections

> FDA Inspection 1304600 for Pfizer Inc. on February 13, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1304600
- Company Name: Pfizer Inc.
- Inspection Date: 2026-02-13
- Product Type: Biologics
- Office Name: Los Angeles District Office

## Related Documents

- [FDA Inspection 1279984 - 2025-08-22](https://www.keypedia.com/records/fda_inspections/pfizer-inc/3faff0d1-6e0d-4b25-a3d7-6f9649566d1b)
- [FDA Inspection 1279984 - 2025-08-22](https://www.keypedia.com/records/fda_inspections/pfizer-inc/7d683157-61f4-47c6-af23-79923d5764b9)
- [FDA Inspection 1206805 - 2023-05-05](https://www.keypedia.com/records/fda_inspections/pfizer-inc/614749ce-b3c6-4879-93e3-6067db5ce1b7)

Company: https://www.keypedia.com/companies/pfizer-inc/b79becc3-ec19-4838-ba1d-fff1abe0c54e

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b